Stevens–Johnson syndrome and toxic epidermal necrolysis: a 20‐year single‐center experience

Citations Over TimeTop 14% of 2014 papers

Abstract

In the present study, nonsteroidal anti-inflammatory and anti-infective drugs were the most frequent causative agents (eight patients in each group). In the group of SJS and SJS/TEN patients treated with ST and SC, the mortality rate was 0%. In TEN patients, the mortality rate was 17.6% (three of 17 patients). There were no significant differences in mortality rate among the three TEN treatment groups, but the results may have been biased by the small number of patients.

Related Papers

• → Toxic epidermal necrolysis: a paradigm of critical illness(2017)34 cited
• → Stevens-Johnson syndrome and toxic epidermal necrolysis(2017)19 cited
• → Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV(2021)4 cited
• → A Case Study of Toxic Epidermal Necrolysis(2019)1 cited
• → Predicting sepsis in Stevens-Johnson syndrome–toxic epidermal necrolysis: Should dermatologists be pro-procalcitonin?(2019)